Varex Imaging Corp Stock Price, News & Analysis

Varex Imaging Corporation (Nasdaq: VREX) will hold its 2022 Annual Meeting of Stockholders virtually on February 10, 2022, at 4:30 pm Mountain Time. This decision is made due to the ongoing public health impact of the COVID-19 pandemic. Stockholders of record as of December 14, 2021 can vote on the meeting's agenda items. Details for attending the virtual meeting and proxy submission will be provided to stockholders.

Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q4 FY21, achieving revenues of $226 million, a 7% sequential increase. The company indicated a strong cash flow of $51 million from operations and improved cash and cash equivalents to $145 million. The non-GAAP net earnings per diluted share were $0.45. For FY21, total revenues reached $818 million with non-GAAP net earnings at $1.31 per diluted share. Guidance for Q1 FY22 anticipates revenues between $200 million and $220 million.

Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q4 and full fiscal year 2021 on November 16, 2021, after market close. Following the earnings release, a conference call will take place at 3:00 PM Mountain Time, which will be available via webcast on their website. Investors can also access the call through specific phone numbers. A replay will be offered until November 30. Varex specializes in X-ray imaging components for medical, industrial, and security applications, supported by over 70 years of innovation.

Varex Imaging Corporation (Nasdaq: VREX) reported strong financial results for the third quarter of fiscal year 2021, with revenues of $211 million, reflecting a 4% sequential increase and a 23% year-over-year rise, propelled by demand in Medical and Industrial segments. The non-GAAP gross margin improved to 36%, while GAAP operating margin reached 12%. The company generated $22 million in cash flow from operations and strengthened its balance sheet by increasing cash equivalents to $128 million. For the fourth quarter, Varex anticipates revenues between $205 million and $225 million and non-GAAP earnings per share of $0.25 to $0.40.

Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q3 FY2021 after market close on August 3, 2021. This will be followed by a conference call at 3:00 PM Mountain Time, which will be accessible via the company's website or through designated phone numbers for U.S. and non-U.S. callers. The call will be archived online, with a replay available from August 3rd to August 17th.

Varex specializes in X-ray imaging components, serving medical, industrial, and security sectors, with a workforce of approximately 2,000 globally.

Varex Imaging Corporation (Nasdaq: VREX) has launched the LUMEN 4336W digital radiography detector, enhancing its product line with features prioritizing durability and convenience. This new detector features a robust design with an IP68 rating, ensuring water resistance for real-world applications. It emphasizes reliability through a simplified internal structure and incorporates wireless charging capabilities. Varex continues to guarantee high image quality, leveraging its expertise in X-ray imaging technology.

Varex Imaging Corporation (Nasdaq: VREX) announced a partial redemption of $30 million from its $300 million 7.875% senior secured notes due 2027, effective July 15, 2021. The redemption price is set at 103% of the principal amount plus accrued interest since April 15, 2021. CFO Sam Maheshwari highlighted that improved financial performance is enabling debt reduction and decreased interest expenses, indicating a positive cash generation trend for the company.

Varex Imaging Corporation (Nasdaq: VREX) is set to present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:30 am ET. The company's CFO, Sam Maheshwari, will discuss Varex’s business and future prospects during the presentation. This event will be available via webcast, with replays accessible for 90 days on the company's website, vareximaging.com. Varex, headquartered in Salt Lake City, Utah, specializes in X-ray imaging components used in medical and industrial applications, boasting over 70 years of innovation.

Varex Imaging Corporation (Nasdaq: VREX) reported strong financial performance for 2QFY21, with revenues of $204 million, a 15% sequential increase, and a 3% year-over-year rise. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 35%. Net earnings were $0.08 per diluted share for GAAP and $0.35 for non-GAAP. Positive drivers included robust global sales of CT tubes and industrial digital detectors. Cash flow from operations reached $13 million, and cash and equivalents stood at $111 million by quarter end.